Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg $47
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg $132
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  3. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  4. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  5. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  6. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  7. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  8. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  9. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  10. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  11. Song R, et al. 2022. Immunology. 165:274. PubMed
  12. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  13. He D, et al. 2022. Immunity. 55:159. PubMed
  14. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  15. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  16. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  17. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  18. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  19. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  20. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  21. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  22. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  23. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  24. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  25. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  26. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  27. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  28. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  29. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  30. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  31. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  32. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  33. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  34. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  35. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  36. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  37. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  38. Chan L, et al. 2022. Cells. 12: . PubMed
  39. Wang L, et al. 2022. Nutrients. 15: . PubMed
  40. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  41. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  42. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  43. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  44. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  45. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  46. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  47. Schick J, et al. 2023. Elife. 12: . PubMed
  48. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  49. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  50. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  51. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  52. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  53. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  54. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  55. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  56. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  57. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  58. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  59. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  60. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  61. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  62. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  63. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  64. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  65. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  66. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  67. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  68. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  69. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  70. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  71. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  72. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  73. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  74. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  75. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  76. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  77. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  78. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  79. Qin C, et al. 2023. iScience. 26:106588. PubMed
  80. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  81. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  82. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  83. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  84. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  85. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  86. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  87. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  88. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  89. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  90. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  91. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  92. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  93. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  94. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  95. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  96. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  97. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  98. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  99. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  100. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  101. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  102. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  103. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  104. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  105. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  106. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  107. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  108. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  109. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  110. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  111. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  112. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  113. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  114. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  115. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  116. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  117. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  118. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  119. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  120. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  121. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  122. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  123. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  124. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  125. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  126. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  127. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  128. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  129. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  130. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  131. Poli V, et al. 2021. iScience. 24:103256. PubMed
  132. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  133. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  134. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  135. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  136. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  137. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  138. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  139. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  140. Chen S, et al. 2022. Cancer Discov. :. PubMed
  141. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  142. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  143. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  144. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  145. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  146. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  147. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  148. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  149. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  150. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  151. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  152. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  153. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  154. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  155. Li B, et al. 2022. iScience. 25:103772. PubMed
  156. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  157. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  158. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  159. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  160. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  161. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  162. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  163. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  164. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  165. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  166. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  167. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  168. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  169. Kasper M, et al. 2021. Elife. 10:. PubMed
  170. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  171. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  172. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  173. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  174. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  175. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  176. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  177. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  178. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  179. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  180. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  181. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  182. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  183. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  184. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  185. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  186. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  187. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  188. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  189. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  190. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  191. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  192. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  193. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  194. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  195. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  196. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  197. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  198. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  199. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  200. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  201. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  202. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  203. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  204. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  205. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  206. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  207. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  208. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  209. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  210. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  211. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  212. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  213. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  214. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  215. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  216. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  217. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  218. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  219. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  220. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  221. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  222. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  223. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  224. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  225. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  226. Gao H, et al. 2021. Cells. 10:. PubMed
  227. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  228. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  229. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  230. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  231. Köchl R, et al. 2020. Elife. 9:00. PubMed
  232. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  233. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  234. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  235. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  236. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  237. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  238. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  239. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  240. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  241. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  242. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  243. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  244. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  245. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  246. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  247. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  248. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  249. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  250. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  251. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  252. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  253. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  254. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  255. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  256. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  257. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  258. Dong S, et al. 2021. Nature. 591:117. PubMed
  259. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  260. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  261. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  262. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  263. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  264. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  265. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  266. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  267. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  268. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  269. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  270. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  271. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  272. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  273. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  274. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  275. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  276. Cho K, et al. 2021. iScience. 24:103117. PubMed
  277. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  278. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  279. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  280. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  281. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  282. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  283. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  284. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  285. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  286. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  287. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  288. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  289. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  290. Dong L, et al. 2022. Cells. 11:. PubMed
  291. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  292. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  293. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  294. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  295. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  296. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  297. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  298. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  299. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  300. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  301. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  302. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  303. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  304. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  305. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  306. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  307. Liu P, et al. 2022. iScience. 25:103867. PubMed
  308. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  309. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  310. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  311. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  312. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  313. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  314. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  315. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  316. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  317. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  318. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  319. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  320. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  321. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  322. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  323. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  324. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  325. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  326. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  327. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  328. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  329. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  330. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  331. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  332. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  333. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  334. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  335. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  336. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  337. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  338. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  339. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  340. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  341. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  342. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  343. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  344. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  345. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  346. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  347. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  348. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  349. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  350. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  351. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  352. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  353. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  354. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  355. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  356. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  357. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  358. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  359. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  360. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  361. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  362. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  363. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  364. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  365. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  366. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  367. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  368. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  369. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  370. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  371. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  372. Tang S, et al. 2022. Virol J. 19:32. PubMed
  373. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  374. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  375. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  376. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  377. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  378. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  379. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  380. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  381. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  382. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  383. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  384. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  385. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  386. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  387. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  388. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  389. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  390. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  391. Wang X, et al. 2022. Elife. 11:. PubMed
  392. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  393. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  394. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  395. Liu SS, et al. 2021. Immunity. :. PubMed
  396. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  397. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  398. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  399. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  400. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  401. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  402. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  403. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  404. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  405. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  406. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  407. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  408. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  409. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  410. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  411. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  412. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  413. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  414. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  415. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  416. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  417. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  418. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  419. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  420. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  421. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  422. Wang S, et al. 2022. Blood. 140:171. PubMed
  423. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  424. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  425. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  426. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  427. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
  428. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  429. Trivedi S, et al. 2020. Elife. 9:00. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV395™ anti-mouse/human CD11b M1/70 FC
Spark Red™ 718 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS B550™ anti-mouse/human CD11b M1/70 FC
Spark YG™ 581 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
StarBright UltraViolet 575 anti-mouse/human CD11b M1/70 FC
StarBright UltraViolet 740 anti-mouse/human CD11b M1/70 FC
Spark PLUS V475™ anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account